Autoimmune hepatitis surgery
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Overview
Liver transplantation is indicated when medical therapy fails, decompensated chronic liver disease, fulminant hepatic failure, hepatocellular carcinoma and MELD score of >15 or a Child-Pugh score of >10277. If AIH recurs after liver transplanation, Reintroduction of corticosteroids and azathioprine is usually given.
Surgery
Surgery
Liver Transplantation
Liver transplantation is indicated in the following condition:[1][2][3]
- Medical therapy fails
- Decompensated chronic liver disease
- Fulminant hepatic failure
- Hepatocellular carcinoma
- MELD score of >15 or a Child-Pugh score of >10277
For more information about liver transplantation click here.
‘De novo’ AIH following liver transplantation
‘De novo’ AIH following liver transplantation
AIH can recur in the transplanted liver. Two patterns of disease are described:[4][5][6][7]
- First, who has detectable anti-LKM1 antibodies at high titer in combination with a serum AST level >500 IU/l,
- Second associated with the presence of ANA or ASMA at lower titers (>1:80) and lower AST levels.
Treatment:
- Reintroduction of corticosteroids and azathioprine.
References
References
- ↑ Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, Miller CM, Sheiner PA (2000). “Liver transplantation for autoimmune hepatitis”. Hepatology. 32 (4 Pt 1): 693–700. doi:10.1053/jhep.2000.16666. PMID 11003612.
- ↑ Ahmed M, Mutimer D, Hathaway M, Hubscher S, McMaster P, Elias E (1997). “Liver transplantation for autoimmune hepatitis: a 12-year experience”. Transplant. Proc. 29 (1–2): 496. PMID 9123100.
- ↑ Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y, Al-Sofayan M, Al-Sagheir M, Al-Sebayel M (2007). “Liver transplantation for autoimmune hepatitis: a single-center experience”. Transplant. Proc. 39 (4): 1166–70. doi:10.1016/j.transproceed.2007.02.030. PMID 17524922.
- ↑ Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, Farahmand H, Gigou M, Féray C, Reynès M, Bismuth H (1999). “Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease”. J. Hepatol. 30 (1): 131–41. PMID 9927160.
- ↑ Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E (1999). “Recurrence of autoimmune hepatitis after liver transplantation”. Transplantation. 68 (2): 253–6. PMID 10440397.
- ↑ Prados E, Cuervas-Mons V, de la Mata M, Fraga E, Rimola A, Prieto M, Clemente G, Vicente E, Casanovas T, Fabrega E (1998). “Outcome of autoimmune hepatitis after liver transplantation”. Transplantation. 66 (12): 1645–50. PMID 9884253.
- ↑ Kerkar N, Hadzić N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G (1998). “De-novo autoimmune hepatitis after liver transplantation”. Lancet. 351 (9100): 409–13. doi:10.1016/S0140-6736(97)06478-7. PMID 9482295.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
